Salix Stock Ranked #1 Among S&P 1500 in post-Lehman Era

Press Releases

Wyrick Robbins congratulates its client, Salix Pharmaceuticals, for ranking #1 in growth in the S&P 1500 Index since the Lehman bankruptcy on September 12, 2008.

For more information and to view a chart of the best and worst S&P 1500 stocks since September 12, 2008, please click here.

 

About Wyrick Robbins

Wyrick Robbins is an entrepreneurial law firm with a focus on growth-oriented businesses. The firm handles financial and corporate transactions and complex commercial litigation as well as other legal needs of dynamic companies. In addition, Wyrick Robbins attorneys serve as trusted advisors to founders, investors, directors, and management.

For more information:

Jennifer Herendeen
jherendeen@wyrick.com
919.781.4000